Sign in
4

Changes in Ownership

HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004240

Options or other derivatives

  • SVP, CHIEF LEGAL OFFICER acquired 48,067 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-12 Grant or award · Performance Stock Units +6,050 17,409 D
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-12 Grant or award · Performance Stock Units +4,698 7,365 D
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-12 Grant or award · Performance Stock Unit +7,269 7,269 D
Snyder Mark Howard SVP, CHIEF LEGAL OFFICER 2025-02-12 Grant or award · Performance Stock Units +30,050 30,050 D
Loading xslF345X05/form4-02142025_110259.xml…